Ocular Therapeutix, Inc(NASDAQ:OCUL) 
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent...
Website: http://www.ocutx.com
Founded: 2006
Full Time Employees: 161
CEO: Antony Mattessich
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.88
H 7.08
L 6.25
C 6.36
V 2,891,957
10EMA 6.36
20EMA 6.36
60EMA 6.36
120EMA 6.36
250EMA 6.36